Research programme: MT 2 derivatives - Mito BioPharma
Alternative Names: MT-2 derivatives - Mito BioPharmaLatest Information Update: 28 Aug 2022
At a glance
- Originator Mito BioPharma
- Class Small molecules
- Mechanism of Action Mitochondrial oxidative phosphorylation uncouplers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Mitochondrial disorders
Most Recent Events
- 28 Aug 2022 No recent reports of development identified for research development in Mitochondrial disorders in USA
- 12 Jul 2018 Mito BioPharma in-licenses mitochondrial uncouplers technology from Rutgers University before July 2018 (Mito BioPharma website, July 2018)
- 12 Jul 2018 Mito BioPharma has patent protection for chemical mitochondrial uncouplers (Mito BioPharma website, July 2018)